Maximus, Inc.

Greetings, and welcome to the Maximus fiscal 2021 second quarter conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, James Francis, Senior Director of Investor Relations for Maximus. Thank you, Mr. Francis. You may begin.

Good morning, and thanks for joining us. With me today is Bruce Caswell, President and CEO, and Rick Nadeau, CFO. I'd like to remind everyone that a number of statements being made today will be forward-looking in nature. Please remember that such statements are only predictions. Actual events and results may differ materially as a result of risks we face, including those discussed in Item 1A of our annual report on Form 10-K. We encourage you to review the information contained in our earnings release today and our most recent forms 10Q and 10K filed with the SEC. The company does not assume any obligation to revise or update these forward-looking statements to reflect subsequent events or circumstances except as required by law. Today's presentation may contain non-GAAP financial information. Management uses this information in its internal analyses of results and believes this information may be informative to investors in gauging the quality of our financial performance, identifying trends in our results, and providing meaningful period to period comparisons. For a reconciliation of the non-GAAP measures presented in this document, please see the company's most recent quarterly earnings press release. And with that, I'll hand the call over to Rick.

Thank you, James. This morning, Maximus reported a strong second quarter for fiscal 2021, with revenue increasing 17.3% to $959.3 million over the prior year period and diluted earnings coming in at $1.29 per share. The company's operating income margin was 11.8% for the quarter. Our better than expected results were driven by the high level of COVID response work revenue in the U.S. segments and employment services work in Australia, which experienced higher than expected volumes of activities. Since our February 4th call, we have continued to win a substantial amount of new work as Maximus plays an integral role helping government customers serve their citizens during the pandemic. Our revenue attributable to COVID response activities, such as contact tracing, unemployment insurance, CARES Act communications, and vaccine communications were $242 million for the second quarter and $402 million year to date. We project COVID response revenue will now range between $800 and $850 million for the full fiscal year. Our Australia employment services business achieved a high level of performance in the quarter as job seekers were able to find and sustain work as the Australian economy opened up. The performance on this contract has improved faster than we projected, resulting in higher second quarter revenue and profit for our outside the U.S. segment. The organic growth rate for the second quarter of fiscal 2021 was 12.8%, or 29%, excluding the Census contract revenue reduction. Results for the quarter included one month of attained operations from the acquisition date of March 1st, which added approximately $20 million of revenue and $3 million of operating income after the expense related to amortization of intangible assets. I will now take you through our segment results, starting with U.S. services. Second quarter fiscal 2021 revenue in the U.S. services segment increased to $448.2 million, driven by an estimated $175 million of COVID response work. The segment operating income margin was 18.5% and reflects better than expected operating results for the COVID response programs that offset the significant revenue and profit headwinds to some core programs related to the pandemic. The segment continues to be affected by the pause in eligibility redeterminations for Medicaid, and the timing of some core programs returning to pre-pandemic levels remains uncertain. I would like to emphasize that we cannot predict the relationship between core program improvement and the conclusion of the COVID response work. Our full-year expectations for the U.S. services segment remain unchanged, with a 17 to 18 percent full-year operating margin predicted. Revenue for the second quarter of fiscal 2021 for the U.S. federal services segment decreased to $330 million due to the conclusion of the census contract, which contributed $133 million less revenue this quarter as compared to the prior year period. As I mentioned earlier, segment results included a one-month contribution from ATTAIN of approximately $20 million. Excluding census, organic growth for the segment was 13% and driven by an estimated $56 million of COVID response work revenue. COVID response work continues to backfill some of the temporary pandemic-related shortfalls created by reduced volumes, revenue, and profit from accretive performance-based contracts in this segment. The operating income margin for U.S. federal was 7%. We announced two acquisitions in the quarter for U.S. federal services. As we disclosed on March 1, ATTAIN is estimated to contribute $120 million to $140 million of revenue for the seven months of the fiscal year. The pro forma trailing 12-month adjusted EBITDA for ATTAIN is approximately $32 million, which indicates ATTAIN is expected to be accretive in fiscal 2021. We present adjusted EBITDA in the management's discussion and analysis section of our Form 10Qs and 10Ks. The full year segment operating income margin expectations for the U.S. federal services segment has improved from 6 to 7% previously forecasted to approximately 8%. This is before including the acquisition of Veterans Evaluation Services, or VES, that we announced on April 21st with an expected close date in our third fiscal quarter. Due to their fixed price nature, the VES contracts will naturally carry an operating income margin that is greater than our U.S. federal historical average over the past three years. Adding in VES, our full-year fiscal 2021 guidance for the U.S. federal services segment improves to between 9% and 10% for segment operating income margins. Turning to outside the U.S. segment, revenue for the first quarter of fiscal 2021 was $180.9 million. This segment experienced the most pronounced negative impacts from the pandemic, and last year's second quarter resulted in an operating loss of $26.7 million. This year, the segment's second quarter operating income was $15.1 million, and the margin was 8.3%. As I mentioned, the better than expected results for the outside the U.S. segment were largely due to Australia, where market conditions continued to create and sustain job opportunities in conjunction with our team pushing performance and efficiency initiatives. On our February 4th call, we noted that there was strong demand for employment services in the outside the U.S. segment. Our employment services contracts typically experience startup losses in the early phases of their operations, and our prior guidance included our best estimate at that time. Since then, we have won more new employment services work than we projected. On April 26th, we announced a significant win in the UK on a program named UK Restart, where we secured two of our preferred regions. In addition to this win, the outside the U.S. segment has exciting new employment services programs in Saudi Arabia, Sweden, South Korea, and Italy. Due to the startup nature of these contracts, there will be startup losses incurred in the third and fourth quarters in the outside the U.S. segment as revenue ramps into the next fiscal year. The U.K. restart is responsible for the largest share of the incremental startup loss. These startup losses are more heavily weighted to the fourth quarter of fiscal 2021. The profitability of all of these outside the U.S. startup contracts is expected to exceed 10% over the life of the contracts, given their performance-based nature and the strong demand for employment services. These contracts range in length from one year to six years. We expect significant improvement to the financial contribution from these contracts in fiscal 2022. With the startup losses, the fiscal 2021 full year margin for outside the U.S. is expected to be in the low single digits, with the fourth quarter swinging to a loss as activity picks up on the UK restart program. Let me turn to cash flow items and the balance sheet. At March 31, 2021, we had $240 million of borrowings on our $400 million corporate credit facility. We had cash and cash equivalents of $101.7 million. DSO was 70 days at March 31, 2021, including attain on a pro forma basis. This compares to 75 days at December 31, 2020, and 72 at March 31, 2020. Cash flows were strong in the quarter, with cash from operations of $181.6 million and free cash flow of $167.1 million for the three months ended March 31, 2021. Given the two significant acquisitions we recently announced, I will expand on my usual capital allocation remarks. The financing required for the VES transaction will result in initial leverage estimated to be approximately 2.7 times debt over pro forma adjusted EBITDA. Pro forma adjusted EBITDA is calculated by using the last 12 months of EBITDA for Maximus in accordance with our existing credit facility. plus estimated EBITDA for attain and for VES, assuming the acquisitions were included in our operating results for the entire trailing 12-month period. Traditionally, Maximus has maintained low leverage. We strive to be good stewards of shareholder capital and believe that we are appropriately selective in the acquisitions we pursue, focusing on those that we believe are both consistent with our strategy and will enable us to drive future organic growth. On the April 21st VES announcement call, I indicated that we would pause significant M&A activity while we integrate Attain and VES. We want to prioritize integrating these two respected companies. Accordingly, we will use most of our free cash flow for the next several quarters to pay down debt. Our aim is to maintain our leverage ratio below 2.5 times. We have long-term contracts and longer-term relationships with customers, solid rebid win rates, and satisfactory new work win rates to assure reasonable and stable operating cash flows in the future. Our expected future cash flows permit us to comfortably pay the debt service, to execute selective tuck-in M&A transactions, to invest in our business organically, and to pay the quarterly dividend, which we evaluate each quarter. We will continue to search for and execute tuck-in transactions that are accretive, deliver good value, and have a strong potential to drive future organic growth. Guidance for the remaining half of fiscal 2021 is complicated by four factors. One, the nature and longevity of COVID response work that we have been winning and performing. Two, the two acquisitions we announced. Three, the impact of the significant startup contracts outside the U.S. And four, the negative impact of the COVID pandemic on some of our core programs. Let me address these factors in that order. First, the COVID response work we have earned to date and project to earn in fiscal year 2021 is much greater than anticipated when we communicated our first quarter results on February 4th. As I mentioned, we are now forecasting $800 million to $850 million of COVID response work in the full fiscal year 2021. We expect this work to diminish over time and accordingly project a drop in the fourth quarter as compared to the third quarter. Second, we have included the acquisition of VES in our guidance, assuming the transaction closes in the beginning of June. When we announced the deal on April 21st, we disclosed the estimated revenue from June through September to be $160 to $175 million. There are one-time expenses of approximately $13 million for the VES transactions. There is interest expense tied to the term loan borrowings that we will use to finance the acquisition. We are still finalizing the intangibles valuation, but based on what we are seeing today, the VES acquisition will be slightly dilutive to earnings per share for the remainder of fiscal 2021. Third, we have startup losses planned outside the U.S. with a more meaningful effect felt in the fourth quarter. Fourth, We are assuming the negative impacts related to the public health emergency persist through the remainder of the fiscal year 2021 as signaled by the January 22nd letter from the then Secretary of the Department of Health and Human Services to the U.S. governors. We are assuming the public health emergency will continue past our fiscal 2021 year end. All of that together, we now expect total company revenue to be in the range of $4 to $4.2 billion for fiscal 21, and our estimated diluted earnings per share to be in the range of $4.20 to $4.40 per share. Cash from operations is expected to be between $400 and $450 million, and free cash flow is expected to be between $360 and $410 million. The guidance range is wider than typical in mid-year, but it's necessary to account for the volatility in the COVID response work. The midpoint of our guidance range for revenue indicates an expected organic growth rate of 9.9% for fiscal 21 as compared to fiscal 20. We also consider the impact of the COVID response work in the census contract and calculated an expected adjusted organic growth rate of approximately 6% for fiscal 21. Our effective income tax rate should be in the range of 26 to 27% for the full fiscal year 2021 and weighted average shares outstanding in the range of 62.2 million and 62.3 million shares. Our effective income tax rate is being impacted by the high level of income in Australia and the reduced income in the UK caused by the startup contracts. The $4.30 midpoint of updated guidance implies reduced earnings in the second half of fiscal 2021 as compared to the first half. We anticipate a step down of third quarter earnings compared to second quarter results, which is primarily driven by some one-time costs for the VES transaction. We anticipate an additional step down of fourth quarter earnings compared to the third quarter created by the increased impact of the startup contracts in the outside the U.S. segment and the reduced forecasted levels of COVID response work. Let me make a few comments as we consider fiscal 2022. The amount of revenue we expect from the two acquisitions is estimated to be between $700 and $750 million. While we do expect some of the COVID response work to continue into fiscal year 2022, it is extremely difficult to predict. Equally hard to predict is the timing and impact of the public health emergency on Medicaid redeterminations and the resulting increase to Maximus revenue. Our forecasting precision remains limited due to ongoing volatility created by the pandemic. as you see with the results announced today as compared to our estimates three months ago. Bruce and I are grateful to our busy and hardworking teams around the world. We are responding quickly to customers needing help with vaccine administration, working hard on large-scale existing and new employment services programs, and beginning to integrate two important acquisitions with valued team members. And with that, I will turn the call over to Bruce.

Thank you, Rick, and good morning, everyone. Since I transitioned into the CEO role in 2018, I've spoken about our three-pronged strategy to accelerate our progress and drive the next phase of our growth through, first, digital transformation within the government services market, enabling new solution offerings to address the mission requirements of our customers and improve overall service delivery across our operations. This began with improved tools for citizen engagement and process automation and is evolving to include new capabilities in artificial intelligence and machine learning, natural language processing, and advanced analytics to enhance our competitive position. Second, clinical evolution to address long-term macro trends driving demand for independent and conflict-free business process management, or BPM, services. with a more clinical dimension, while maintaining the foundational elements of our business, operating customer engagement centers, and providing case management services. And third, market expansion, as we evaluate adjacent and emerging markets, organically grow the portfolio, and acquire capabilities and contracts to establish a foothold in these markets. We also consider our customers' longer-term visions for reengineering social program delivery models and, of course, macro trends. We aim for expansion that's a natural complement to our core services globally. Today, I will focus on how recent efforts are aligning with these three strategic priorities, including the two acquisitions, recent wins, and COVID-19 implications. As you know, in March, we announced the acquisition of the federal business of Attain. furthering two of our primary strategic pillars by, first, accelerating our digital transformation by strengthening our technology capabilities in application development and modernization, enterprise business solutions, cybersecurity, and the data sciences, including advanced analytics and machine learning. These capabilities address federal IT spending imperatives and priorities, while also being applicable to our BPM solutions. And secondly, expanding further in the U.S. federal market into new departments and agencies such as the Securities and Exchange Commission and Department of Homeland Security, as well as within our common clients such as the Department of Health and Human Services. While our integration is still in its early days, already I'm pleased to see how our teams are working together to address pipeline opportunities with our strongest capabilities and to share experience and skills to improve the solutions we're delivering to our federal customers. As I spoke of briefly when we first announced the transaction, Attain brings innovation and experience in many competencies that are in greatest demand in federal, while Maximus brought scale and highly desirable contract vehicles like Alliant 2. Together, we can now address opportunities where neither company would have previously been competitive. Further executing on our strategy, We most recently announced an agreement to acquire privately held Veterans Evaluation Services, or VES, a premier provider of medical disability examinations, or MDEs, to the U.S. Department of Veterans Affairs, the VA. This significantly advances our strategic aim of clinical evolution while meaningfully expanding our presence in the VA. As Rick stated, we expect to close this transaction in the third quarter. While our independent clinical assessments business has been growing at the U.S. state level through our 2016 acquisition of Ascend and subsequent organic growth primarily in Medicaid-related long-term care assessments, VES's expertise will create an opportunity for such growth at the federal level. As a result, the independent health and disability assessments and appeals portion of our business will comprise a larger share of our overall portfolio and pipeline. lending further credibility to our organic growth efforts with other federal departments and in non-federal markets. The acquisition comes at an important time for the VA, as the Veterans Benefits Administration, or VBA, has been focused on reducing the inventory of exams that naturally has grown during the pandemic while preparing for the future needs of veterans with qualifying conditions. To that end, and as they've done periodically in the past, The VBA recently launched a market assessment to better understand industry capacity and capabilities. Through our combination, we believe Maximus and VES bring the credibility and quality of an established partner and ability to rapidly add clinical capacity and invest in technology innovation that will benefit veterans and the VBA. Our goal is to both contribute to the timely reduction of pandemic-related inventory and be the partner of choice as the MDE program continues to develop. Our acquisitions of Attain and VES, as well as Essentia in 2015 and Citizen Engagement Center operations from GDIT in 2018, help us play a more meaningful role in the U.S. federal market as we build scale, expand, and diversify our customer base and improve our competitive advantage. Concurrent with these acquisition efforts, we continue to win COVID-19 related work at the state and federal level, as Rick discussed in his remarks. This includes the recently posted CDC vaccination hotline award, illustrating the trust that government places in Maximus based on our historical performance. While COVID-19 work is generally planned to be shorter term in nature, we remain well positioned to adjust as the pandemic related needs of our customers continue to evolve. These efforts also allow us to meet new customers, expand into new areas of service with existing customers, and increase our impact on their behalf. Through this work, we build longer-term references and past performance credentials that are advantageous in future bidding. For instance, in areas like unemployment insurance, the demonstrated value of our model is creating opportunity for longer-term relationships with state departments of labor as they see the benefits of the flexibility and accountability we can provide in delivering outcomes that matter in more routine program areas. Further, our ability to stand up solutions quickly during challenging times using effectively our modular capabilities makes event-driven work a beneficial element of our business model in response to less predictable but regularly recurring government needs. Our investment in the digital transformation of citizen services coupled with our decades-long experience, have been recognized by our government customers during this pandemic as we responded to real-time requests to quickly deliver support and services. Our outside-the-US teams are securing some exciting new wins as well. As Rick mentioned, in the United Kingdom, We were recently awarded two prime contracts in our preferred regions to deliver the restart program, which provides 12 months of tailored and community-based support for people that have been unemployed long-term and directly impacted by the pandemic. This contract was procured through the CARES framework, which I mentioned in my remarks in the fourth quarter of the last fiscal year, and is used for contracting national employment support programs. Adding emphasis to Rick's earlier point, startup costs are typical with significant new contracts like this one. Therefore, we anticipate Q3 and then Q4 earnings will step down sequentially as a result, followed by a subsequent rebound driving earnings estimates upward in fiscal year 2022. These programs create long-term shareholder value and will operate within our expected corporate range of profitability. This is not the first time we've accepted startup losses for a longer-term and more significant future benefit. In total, the two contracts, the maximum that could be won by a single provider, are valued at more than $960 million, 690 million British pounds sterling, over the base and option periods totaling six years. Maximus UK will be recruiting more than 1,500 people to deliver the programs. We have a long history of supporting workforce services in the UK, establishing our foothold in the UK employment and training marketplace in 2008 during the economic recession. This solid platform, history of excellent performance, and strong client relationships have provided the necessary credentials to expand employment-focused programs as illustrated by this award. While this new work has provided some positive offset, our core operations in the UK continue to face disruption as a result of the pandemic. This negative impact continues to be driven by temporary volume and revenue declines, as well as a pause on face to face assessments. Although we continue to face decreased volume across some of our geographies in Australia, we are seeing strong volumes as the economy reopens. Demand is holding more than we anticipated during the holiday season and serves as an example of anticipated volume return as certain countries slowly begin to emerge from the pandemic. All in all, we will remain dedicated to addressing COVID-19 implications with our customers while driving organic growth opportunities across the business. In that spirit, I will now turn to new awards and pipeline as of March 31st. As of the second quarter of fiscal 2021, Signed awards were $1.11 billion of total contract value at March 31st. Further, at March 31st, there were another $1.28 billion worth of contracts that have been awarded but not yet signed. I should note that the CDC vaccination hotline and UK restart contract awards were subsequent to our March 31st cutoff. Let's turn our attention to our pipeline of addressable sales opportunities. Our total contract value pipeline at March 31st was $35.6 billion compared to $31.6 billion reported in the first quarter of fiscal 2021. Of our total pipeline of sales opportunities, 67.4% represents new work. On a final note, I'm excited to welcome our newest team members from Attain, and I'm looking forward to doing the same for our prospective colleagues from VES when the transaction closes. The hardest thing to get right in any integration is culture, and we've been very focused as an integrated leadership team on getting that right for all employees. Our goal for our colleagues from both Attain and VES is that you will have more opportunities to take on new challenges to advance your careers and to be rewarded for quality work. I want to congratulate and thank the Maximus team around the globe for their ongoing efforts during the pandemic to keep our employees safe, providing high-quality and innovative solutions to our customers, and best-in-class service to the individuals and families we serve. We've been fortunate to have been well-positioned to respond to the needs of government at a very challenging time. This has been possible only through the efforts of more than 35,000 colleagues worldwide and tens of thousands of delivery partner staff. On behalf of the entire Maximus leadership team, we thank you. And with that, we'll open the line for Q&A. Operator?

Thank you. We will now be conducting a question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star 2 if you would like to remove your question from the queue. We ask that you limit your follow-up questions to one so that others may have an opportunity to ask questions. You may re-enter the queue by pressing star 1. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. One moment, please, while we poll for questions. Thank you. Our first question comes from the line of Charlie Strauser with CJS Securities. Please proceed with your question.

Good morning. This is Brendan Popsin on for Charlie. Fantastic quarter, obviously, and I wanted to dig into the Outside the U.S. performance, and you guys alluded to this talking about Australia, but the high single-digit margin was unexpected. I know you talked about the employment services being strong and high retainment going on with the employees. I wanted to ask just like how sustainable that margin is and if you could just dig more into the puts and takes there and what we could see down the road.

Hey, Brendan. Good morning. It's Bruce. Thanks so much for the question. I'm going to turn it over to Rick to address and I'll add a little commentary perhaps at the end. Thanks so much.

Yes, thank you. You know, with respect to Australia first, you know, the first quarter we told you that they were coming out of a lockdown. And they had strong demand during that Christmas period due to the fact that there was a lot of pent-up demand from the employers who needed to quickly fill some of those retail and travel-related jobs. Those are industries that we typically place a lot of people in. In Q2, our fiscal year Q2, they also achieved good financial performance on their caseload metrics and sustainments, or what we also call retentions. This really means that more people will be replaced and more people will be able to sustain their jobs or retain them. And that shows that Australia has really come out of their pandemic better than other countries around the world. The macro trend should really be in our favor down there. There is difficulty, though, predicting what happens quarter to quarter due to the pandemic, but Australia looks very good and is doing really well. I think embedded in your question is really also about those OUS startups, the outside US startups. Those are in multiple geographies, some of which are countries we've operated in for several years and others which are new to us. Those are outcomes-based contracts which typically take time to build up the volumes. This gives you economies of scale over time. However, in the early phases of a contract, our costs ramp up at a quicker rate and that will create initial losses. So the revenues will come slower than the costs that ramp up. So we anticipate several quarters of losses on these contracts before they turn profitable. This will be a bit of a drag to the OUS segment results in FY21. And as I noted, I think the startup contracts will drive an operating loss in the fourth quarter of our fiscal 2021. As Bruce mentioned, we do believe that these These contracts are a good investment for us. They make sense due to the overall favorable economics over the life of these contracts. We do expect these contracts to deliver 10% plus operating income margins over their life. Does that answer your question, Brandon?

Yes. Yeah, that's great. But I also want to ask about the pipeline Bruce was talking about with the increase, obviously, from VES and Attain. and what's assumed in the pipeline from that, and then more than that, I guess, you know, what's the potential pipeline expansion from the acquisitions?

Sure. Brendan, I'll take that to begin with and ask Rick to chime in as well. I importantly want to note that there's no VES in the pipeline because the transaction has not closed, right? And also, historically, I can just give you a little more color. Historically, VES really hasn't had kind of a business development function. They have been completely focused on serving their VA customers, well, you could imagine. And so if there's deals that will be additive to the pipeline, Once the transaction closes, it will likely be synergy opportunities that we've identified as part of the process of getting to know VES, understand their capabilities, and taking a longer-term view of where their capabilities could be applied to other kind of areas of white space in the federal government. I WANT TO ALSO, HOWEVER, SAY THAT LIKELY THOSE PIPELINE OPPORTUNITIES WILL BE MORE LIKE TWO TO FOUR YEARS OUT AND NOT IMMEDIATE BECAUSE WE'RE ABSOLUTELY 100% FOCUSED AS WE COME TOGETHER WITH BES IN WORKING WITH THE BBA ON THE INVENTORY, AS I MENTIONED IN MY PREPARED REMARKS, THAT'S BUILT UP DURING THE COVID PANDEMIC PERIOD AND ALSO TO ENSURE THAT They are very well positioned to address the needs of veterans for whom it's a dynamic program, and periodically Congress will authorize new benefit categories, and that creates demand that needs to be addressed. So that is absolutely our focus, which is bringing capacity and scalability and further capabilities to serve the VA. And then we would hope that over time, in due course and at an appropriate time, there would be additional pipeline opportunities for us to pursue. So that's the ES piece. Rick mentioned that we did see a meaningful uptick, a small uptick in our pipeline as we came together with Attain. You can imagine the process. is that the companies went through and scrubbed the pipeline to make sure that if there are any deals that overlap that we were both pursuing and looking at, we eliminated the overlaps. And then we looked at the pipeline that Attain brought over. And then we also looked at, are there deals now that we will be able to, as I mentioned in my remarks, pursue because of the combined capabilities of Maximus and Attain? I would say that the pipeline reflects A minimal number of those presently because we're still only getting started with Attain and really understand kind of what the combined capabilities now mean in terms of larger deals that we can bid and editors that we can go against. So the additive component to the pipeline would be really just what came over as that was in Attain's pipeline at the time of the transaction. which was not insubstantial. I'm very pleased with and I think the team's done a great job of positioning for those deals. Just to give you a little more sense of behind the scenes, you know, we make sure that if teams have been both looking at opportunities, we're looking at which team is best positioned in terms of customer relationships and, you know, teaming agreements that may have been developed and so forth to capture the deal. And there's been just a great level of collaboration between the Legacy Attain and Maximus teams in that regard. Hope that answers your question, Brendan. Is there anything further?

Yeah, definitely. I'll hop back in the queue. Great.

Thanks, Brendan. Operator, next question, please.

Our next question comes from a line of Donald Hooker with KeyBank Capital Markets. Please proceed with your question.

Great. Good morning. A lot of moving parts here. I guess maybe I'll ask a question about the state Medicaid redetermination, sort of the pause there. Can you help us think through kind of, I'm sort of imagining that there will be a release of work for you, some sort of bolus release of work for you at some point, maybe in fiscal, maybe next year, I don't know. But can you help us think through kind of what that could look like? I mean, how do you see these Medicaid programs getting back to sort of normal operations with these redeterminations?

Sure. Bruce, why don't I go ahead and begin and then ask Rick to add to this. I think it was, I want to say January 22nd, there was a letter that was sent by the then acting secretary of HHS to all the governors indicating the intent of the Biden administration to extend the public health emergency through the end of calendar year 2021. We're taking our guide off of that, if you will, and therefore everything that we've spoken to in terms of our view of when redeterminations would resume and the impact on the fiscal year is that this public health emergency will extend through the end of the calendar year at the very, I guess, earliest, given what's been said publicly. You can imagine that there will be then a period of a couple of months, probably, you know, after the end of the calendar year as things ramp up and get going again. Our view would be that certainly there's a backlog that has been building up because common practice is to redetermine, you know, eligibility for certain tranches of the existing population on a periodic basis. And with that not having been done, it needs to be caught up. And so we would expect there to be some backlog related to that that will need to be worked through as we turn the corner into the next calendar year. That work historically has benefited from the scale economies of our operations. In other words, once you've already stood up an operational center that has you know, a back office processing capability, a mail room, you know, a document sorting and inspecting function, eligibility staff that review applications but can also do redeterminations. You can imagine that incremental volume related to redeterminations is can be handled with a lot of existing infrastructure. So we expect that work to be more accretive in nature when it comes back on than the standard kind of base eligibility work that we do.

But, Rick, would you add anything further? Yeah, just three quick little quick things. First off, you know, we are assuming, we are not assuming the pandemic-related headwinds abate during the remainder of this fiscal year. So we're assuming that It does not help this fiscal year. Logic does tell us that there should be backlog. When this becomes work for us is really tough to determine. But Bruce is right. When that does occur, that should be profitable work whenever that catch-up happens.

Okay. And then in terms of you guys mentioned some employment services work in the outside of the U.S. segment. I think you mentioned some countries that I'm not familiar with Maximus being involved in. Catch me if I'm wrong. I think Sweden, South Korea, Italy, I think you have some work in Saudi Arabia. But are these new geographies for you? Does this open up potentially new doors for Maximus over the next few years in these countries?

Yeah. Don, let me catch you up a little bit on that and then ask Rick again to comment. So to begin, the significant opportunity that we're seeing, obviously, we spoke to the UK restart opportunity. But we had completed previously, and it gets maybe lost in the, like you say, a lot of moving parts here, a small tuck-in acquisition. in South Korea, and that small acquisition was in response to a market trend that we identified where the government was going to be requiring companies of much larger sizes than had been required historically to use privately provided employment service providers to place displaced workers back into employment. So we always look at, kind of going back to conversations we had with Rich Montoni, not just the propensity to outsource, but a change in the propensity to outsource. policy signaled a shift. The reason we approached it with the token acquisition is that time was of the essence because that policy was being implemented quickly and we didn't have the opportunity to enter organically. By contrast, we did recently organically begin operations in Sweden. And that was in direct response to the major policy plank of the coalition, the primary or majority party of the coalition government that had really run on a premise or principle of reforming the public employment system, which they felt was not... successful for Sweden. So there's an existing program, but also a new program that is being administered where cases are being transferred to the new one, the program's being expanded. And we felt as we looked at that situation, we had the ability to create the business and build the business organically, and that's exactly what we've done. As it relates to Saudi Arabia, we have had a strong business in Saudi Arabia historically. that has primarily focused on employment services. We've seen an opportunity there recently to grow that business as the government is both focused on driving employment, re-employment of Saudis in a post-pandemic era, but also continuing to advance the Saudization policy and initiative, which is to provide primary employment opportunities to Saudi citizens in lieu of historical policy that also had a significant portion of foreign workers in the workforce. In response to those trends and also the government's desire to continue to think about training and upskilling their citizens to take on kind of jobs of the future, we've seen opportunities develop in Saudi Arabia as well. I think the last one that we haven't talked about is Italy. Italy, we similarly were following... really a shift in policy that signaled an opportunity to do some work there, and that related back to the historic use of European Social Fund money or ESF funds to fund employment services. Without dragging you through the weeds of the policy change, We saw an opportunity to enter the market. We began, again, organically with a small business in Emilia-Romagna, and we've been able to expand into Lombardi as well. Actually, I reversed the two. It began in Lombardi and then went to Emilia-Romagna. And we're pleased with the operation of that program presently. given the overlay of the pandemic. You know, certainly Italy was, as you all know, extremely hard hit by the pandemic and it's taken some time to recover. But that method of privately provided employment services still remains a great priority of the government. I lay all that out to say we are very, very deliberate, always extremely deliberate about decisions to begin businesses in new countries. And it is not our policy or our plan around here to plant flags, but rather to look at the market very carefully, evaluate it across a broad number of risk factors, and only move into a new market area when we believe it has the potential to deliver long-term growth for our shareholders and to support multiple business lines for Maximus. So not just in the employment services space, but also in the health-related areas over time. So sorry for the long answer, but that's kind of the strategy as we're executing it and catch up on those. Rick, is there anything further you want to add? No, that's a very complete answer.

Yeah, that's a Super helpful, Becca. Thank you. Thanks so much.

Sure. Hey, Don, we'll keep your line open.

Do you have any other questions for us? Sure. And then maybe for the – have you all quantified sort of as we think about fiscal 22, some of the U.K. deals, the two – the restart program? kind of when that sort of ramps up. It's a big, big program for you guys. When that would sort of hit full run rate, is it a year, two years, three years? It's a multi-year program. So when would that hit full run rate and margin?

Yeah, you know, that's obviously hard to gauge. We're generally thinking it takes us a while to get that going, but I would think the second half of fiscal year 22 would be when you would see those revenues catch up. So what you really have happening there, Don, is that the costs ramp up and you're serving the citizenry, but the volumes take a while to catch up with that. And so as I said, I think it's about four quarters, the second half of fiscal year 22. Okay, great. Thank you.

Thank you. Thanks, Don.

Operator, back to you.

As a reminder, if you would like to ask a question, press star 1 on your telephone keypad. Our next question is a follow-up from Brendan Popsin with CJS Securities. Please proceed with your question.

Thank you. Just wanted to ask real quick on the redeterminations. Are there, obviously some, there's different, you know, there's different policies that different states are following and, you know, some states are doing, have more restrictions than other states. Is there a difference? Are some of your states going to come back sooner than others, or is there some kind of central authority that means that not much of it will come back until after the public health emergency is over?

Yeah, it's the latter, Brendan. The way it works is that in order for states to continue to receive enhanced federal matching funds during the pandemic, they have to agree to what historically has been referred to as kind of MOE or maintenance of effort on the program. I think they can't erode any types of any types of services that they're providing or diminish any services they're providing. And that means they need to do everything they can to keep existing Medicaid beneficiaries on the roll. There are some mechanics that we can share with you. Maybe offline it would be best in terms of once the public health emergency has been declared to be over, there's a period than when they can resume these activities. As I mentioned previously, it's not absolutely immediate, and I think it's actually tied to when they last received funding related to the program. But we'll clarify that for you. The point being, though, that all states have to follow that same set of rules that have been laid out by CMS. And you're right, while there are differences in the way states administer their programs, in this specific instance, as it relates to this population, they can't, you know, I guess they theoretically could jump the gun and begin the process sooner, but they would lose out on the enhanced federal money, and nobody really wants to do that.

Okay, yeah, that makes sense. And I just want to ask about a capital allocation question. You guys talked about your pro-forma. leverage. What's your view on deleveraging? Is that going to be a main priority? Are you comfortable letting EBITDA grow into it, or what's your priority there?

Yeah, Don. It's Rick. I'm sorry, Brandon, it's Rick. Yeah, these are two respected companies that we want to do a very good job on with integration. This integration is going to take us a while, I think, say at least two quarters to really get it done. We have good free cash flow each quarter, and I would say that we will pause significant M&A, get the integration done right, and have our debt paid down. below a 2.5x. That is really our aim, is to keep our leverage below 2.5x. I mean, we're starting off at an area of 2.7x that we're comfortable with, but I think overall, over the long term, staying below 2.5x would be our aim. Great. Okay. Thanks, Brandon.

Operator, back to you. Next question, please.

Our next question is a follow-up from Donald Hooker with KeyBank Capital Markets. Please proceed with your question.

Great. Yeah, one question I meant to ask. I appreciate your time here. In the federal services segment, you mentioned that the addition of VES would sort of create a close to 10% margin, I guess, for the full year, if you include that. That looks like it you're signaling a fairly large step up in operating margin, I guess, in the fiscal and the September quarter. So I guess as we go into next year, can you help us think about what a normalized pro forma operating margin would be for the federal services with the higher margin VES business? I'm thinking that's a pretty material change for next year.

Yes, Donald. Yeah, I do think that if we look forward, that should be able to give us a 10% or better operating income margin. I would say that you have to always recall that we have a large cost reimbursement style contract in that 1-800 Medicare contract that carries a lower margin. But, yes, we should have higher margins from both ATTAIN and VES, and some of our legacy work has also been somewhat camped down by the pandemic, and that should come back. So, you know, we should have 10% plus operating income margins in U.S. federal in fiscal year 22. Okay.

Thank you. Thanks, Don. Any more questions? If not, we'll go back to the operator.

Thank you. Ladies and gentlemen, we have reached the end of the question and answer session and are out of time for today's call. Maximus thanks you for your time and participation today. You may disconnect your lines at this time.